Nestle Q2 results on July 27, 2001

A meeting of the Board of Directors of Nestle India Ltd has been convened on July 27, 2001 to consider unaudited financial results for the quarter ended June 30, 2001.

Indal Board approves expansion of smelting capacity at Hirakud unit

Indian Aluminium Co.Ltd (Indal) has informed BSE that the Board of Directors of the Company at its meeting held on July 09, 2001 has approved an expansion of the smelting capacity at its Smelter at Hirakud, Orissa from the existing 30,000 tonnes per annum to 57,000 tonnes per annum.

Dr Reddys Q1 results on July 31, 2001, Board to consider stock split

A meeting of the Board of Directors of Dr. Reddy's Laboratories Ltd will be held on July 31, 2001 to consider among other things the following: 1. The Un-Audited financial results for the quarter ended June 30, 2001. 2. To consider the sub division of equity shares into shares of smaller amount 3. To consider issue of shares under the employees stock options scheme

Hindustan Zinc Q1 results on July 25, 2001

A meeting of the Board of Directors of Hindustan Zinc Ltd is scheduled to be held on July 25, 2001 to consider the quarterly un-audited results of the Company for the quarter ended on June 30, 2001.

Tata Chemicals Q1 results on July 26, 2001

The Board of Directors of Tata Chemicals Ltd will meet on July 26, 2001 to consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2001.

Dabur India Q1 results on July 26, 2001

A meeting of the Board of Directors of Dabur India Ltd is scheduled to be held on July 26, 2001 to consider the Unaudited Financial Results of the Company for the quarter ended June 30, 2001.

Bajaj Auto opts for 5-day week for daily workmen at Akurdi plant

Bajaj Auto Ltd has informed BSE that owing to the general slow-down in the economy, the changing preference of customers from scooters to motorcycles and the onset of monsoon and the consequent sluggishness in the demand for scooters, the Company has decided to have a 5 day week for the daily-rated workmen at its plant at Akurdi, Pune effective from July 13, 2001. The Company however, will review the situation from time to time with a view to restoring a 6-day working week.

E.Merck H1 results on July 18, 2001

A meeting of the Board of Directors of E.Merck (India) Ltd will be held on July 18, 2001 to take on record the Unaudited Financial Results of the Company for the half year ended June 30, 2001.

Indian Oil Q1 results on July 31, 2001

A meeting of the Board of Directors of Indian Oil Corporation Ltd is scheduled to be held on July 31, 2001 for taking on record the Unaudited Quarterly Financial Results for the first quarter ended June 30, 2001.

VSNL announces 100% Dividend (plus 400% Special Dividend)

Videsh Sanchar Nigam Ltd has informed BSE that the Board of Directors of the Company at its meeting held today (July 10, 2001) has recommended a normal Dividend of Rs 10 per share and a special one time dividend of Rs 40 per share totalling to Rs 50 per share of face value of Rs 10 each for the year ended March 31, 2001. This special Dividend coincides with the listing of VSNL scrip on New York Stock Exchange. VSNL is the only PSU listed on NYSE as of date.

Emami fixes Book Closure as per scheme of arrangement

Emami Ltd has fixed the period from August 9, 2001 to August 14, 2001 as book closure as per the Scheme of Arrangement for de-merger of investment undertaking of Emami Ltd., between the Emami Ltd. and Pan Emami Cosmed Ltd.,(presently unlisted company) As per the scheme, one equity share of Rs.10 each fully paid-up of Pan Emami Cosmed Ltd., will be allotted for every one existing equity share of Rs.10 each fully paid up of Emami Ltd., held. Transactions in the equity shares of the aforesaid Company will be on cum-entitlement basis upto July 13, 2001 and on ex-entitlement basis from July 16, 2001.

Lupin Chemicals fixes Record Date for reduction in share capital

Lupin Chemicals Ltd has fixes July 30, 2001 as the record date for the purpose of Reduction in share capital of Rs.33,55,08,650 divided into 3,35,50,865 equity shares of Rs.10 each to Rs.3,35,50,865 by effecting a reduction of Rs.9 per share in the paid up value of Rs.10 per share and such reduction is to be effected by consolidating into 33,55,086 equity shares of Rs.10 each fully paid up. There will be no dealings in the aforesaid scrip from July 16, 2001.

Ranbaxy Lab appoints new Directors

Ranbaxy Laboratories Ltd has informed BSE that the Board of Directors of the company has approved as under: 1. Appointment of Mr.Vivek Mehra as an Additional Director on the Board of Directors of the company. 2. Appointment of Dr.Brian W. Tempest, President-Pharmaceuticals of the company as a Whole-time Director of the company.

Chowgule Steamships Board proposes disposal of two vessels

Chowgule Steamships Ltd has informed BSE that the Board of Directors of the company has proposed the disposal of two-vessels namely m.v. Maratha Majesty and m.v. Maratha Mighty, subject to necessary approvals. Extra Ordinary General Meeting of the company will be held on August 07, 2001.

BSE imposes Special Margin on 5 scrips

BSE has informed members of the exchange that Special Margin in the under mentioned scrips has been imposed as mentioned alongside with effect from today (July 10, 2001). Code Name Group Sp.Mg(%) 32377 BATHINA TECHNOLOGIES ( INDIA ) LTD B1 25 32403 FOURTH GENERATION INFOSYSTEMS LTD B2 50 32015 GRAVITY ( INDIA ) LTD B1 25 12299 STERLING BIOTECH LTD B1 25 32382 BALAJI TELEFILMS LTD B1 25

Infosys Tech announces results as per GAAP standards

Infosys Technologies Ltd has posted a net profit of Rs 1900.30 million for the quarter ended June 30, 2001as per Indian GAAP. The net profit as per US GAAP for the quarter ended June 30, 2001 is at Rs 1841.20 million. The reasons for differences in net income as per Indian GAAP and US GAAP is due to amortization of deferred stock compensation expenses Rs 59.10 million. The Company has reported that the US GAAP requires the accounting of deferred stock compensation on issue of stock options to employees, being the difference between the exercise price and the fair value as determined by quoted market prices of the common stock on the grant date. In complying with this requirement, Infosys has charged to revenue under US GAAP an amount of Rs 59.10 million for the quarter ended June 30, 2001 as deferred stock compensation.

Sesa Goa Q1 results on July 31, 2001

A meeting of the Board of Directors of Sesa Goa Ltd is scheduled to be held on July 31, 2001 for taking on record the Unaudited Financial Results of the Company for the quarter ended on June 30, 2001.

Infosys Tech Q1 PAT up by 56.66%

Infosys Technologies Ltd has posted a net profit after tax (before extra-ordinary items) of Rs 1900.30 million for the quarter ended June 30, 2001 as compared to Rs 1213 million in the quarter ended June 30, 2000. Net Sales for the quarter ended June 30, 2001 stood at Rs 6125.20 million as compared to Rs 3555.30 million in JQ 2000. Other income has declined from Rs 151.10 million in JQ 2000 to Rs 134.90 million in JQ 2001. The Company had earned an extra-ordinary income of Rs 54.90 million in JQ 2000 after consideration of which the net profit stood at Rs 1267.90 million for the quarter ended June 30, 2000. During the quarter ended June 30, 2001, the company made a strategic Investment of Rs 103.30 million (US$2.2 million) for 4,40,000 fully paid Series B convertible preferred stock (par value US$ 0.001), issued at US$5.00 per share, in Workadla Inc., USA (Workadla). Workadla will provide companies with comprehensive, customizable business intranets through browser-accessed hosted portals. The company expects a total income between Rs 6250 million and Rs 6400 million and EPS is expected to be between Rs 28 & Rs 29 for the quarter ending September 30, 2001. Total Income is expected to be between Rs 25000 million and Rs 25600 million and EPS is expected to be between Rs 118 & Rs 121 for the fiscal year ending March 31, 2002.

Silverline's Offshore Quality Assurance Testing Lowers Support Calls/Sales Ratio for ePublising Pioneer MightyWords

Silverline Technologies Ltd has announced that it has been contracted by MightyWords. Inc., the Internet's premier seller and distributor of unique digital content, to perform all quality assurance (QA) testing on MighyWords' eCommerce site. MightyWords is the leading source for mid-length, must have, need-to-know digital content in the business and technical categories. MightyWords has created The Mighty Network by enabling distribution partners to seamlessly offer their own collections of MightyWords titles from their Web sites, effectively helping them earn non-advertising based revenues. Business and computing professionals can browse the MightyWords Web site (www.mightywords.com), purchase eMatter, a term coined by MightyWords to describe business, computing, market research and professional information that is between 10 and 100 pages, and is longer than a magazine article but shorter than a book, download it directly to their Windows, Mac, or UNIX PCs, and read it on the screen, or print it out. MightyWords' new website, which went live in December 2000, enables buyers to easily download, 'unlock' and read by copyright-protected publications after purchasing them. In addition, the company is developing a worldwide channel of distributors, an co-brand and sell its products through their websites by downloading a catalog template, customizing the catalog to meet their needs, and then using the Mightywords site as their 'backend' fulfillment and purchasing system. "Our website is very sophisticated," said Hawke Robinson, CTO for Mighty Words. Before we were up and running, we realized we needed to do a through QA test to ensure that we delivered a high-quality user experience to out customers. This included a complete QA review for out newly developed digital rights management (DRM) feature- a software 'lock', which protects our authors and publishers copyrights and prohibits illicit redistribution of our eMatter content. Because our website is our business, time and money were of essence. The code that we needed to test was mission-critical so a lot was riding on our decision. We interviewed more than a dozen consulting companies to find a group that had the methodologies and self-discipline to keep us on track. Only one company, Silverline Technologies, really stood out from the crowd".

UTI Bank denies news item

With reference to the news article appearing in a leading financial daily titled " RBI pulls up UTI Bank, Centurion for flouting market exposure" UTI Bank Ltd has informed BSE that the Bank had at no point of time exceeded limits for exposure to the capital markets set by either the Reserve Bank of India or limits set by its Board of Directors. The Reserve Bank of India had, however, advised the Bank that in the interest of reasonable risk management principles; the Bank should freeze existing limits of exposure to the capital market and take steps to reduce the present outstandings. The Bank has stated that it has complied with the directions of the Reserve Bank of India.

Money

Rapid Information on Stocks & Corporates

Tell us what you think of this report